ALISO VIEJO, Calif., March 19, 2025 /PRNewswire/ — Terumo Neuro, a global leader in neurovascular innovation and a wholly owned subsidiary of Terumo Corporation, proudly marks the 15th anniversary of ...
A prospective multicenter study of 59 Chinese patients with unruptured WNBAs treated with the WEB™ device showed a 98.3% technical success rate. At one year, 82% achieved adequate occlusion and 56% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results